Xencor (XNCR) Cash from Investing Activities (2013 - 2026)

Xencor (XNCR) reported Cash from Investing Activities of $26.7 million for Q1 2026, up 95.18% year-over-year from $13.7 million in Q1 2025, and down 62.52% quarter-over-quarter from $71.2 million in Q4 2025.

Xencor (XNCR) Cash from Investing Activities (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Cash from Investing Activities data on file, last reported at $26.7 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at $26.7 million, up 95.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $153.0 million (up 676.86% YoY), and the FY2025 annual result was $140.0 million, up 1878.26% from the prior year.
  • Cash from Investing Activities declined to $26.7 million in Q1 2026 per XNCR's latest filing, from $71.2 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $71.2 million in Q4 2025 and troughed at -$203.1 million in Q4 2023.
  • A 5-year average of -$4.2 million and a median of $24.5 million in 2022 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2023 and 2024: Cash from Investing Activities slumped 927.48% in 2023, then jumped 4798.65% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at $24.5 million in 2022, then tumbled by 927.48% to -$203.1 million in 2023, then jumped by 128.18% to $57.3 million in 2024, then rose by 24.32% to $71.2 million in 2025, then tumbled by 62.52% to $26.7 million in 2026.
  • Business Quant data shows XNCR's Cash from Investing Activities at $26.7 million in Q1 2026, $71.2 million in Q4 2025, and $14.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Xencor 953.38 Mn 878.64 Mn - 26.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 26.68 Mn
Mar 31, 2026 26.68 Mn
Dec 31, 2025 71.17 Mn
Dec 31, 2025 71.17 Mn
Sep 30, 2025 14.67 Mn
Sep 30, 2025 14.67 Mn
Jun 30, 2025 40.48 Mn
Jun 30, 2025 40.48 Mn
Mar 31, 2025 13.67 Mn
Mar 31, 2025 13.67 Mn
Dec 31, 2024 57.25 Mn
Dec 31, 2024 57.25 Mn
Sep 30, 2024 -163.46 Mn
Sep 30, 2024 -163.46 Mn
Jun 30, 2024 66.02 Mn
Jun 30, 2024 66.02 Mn
Mar 31, 2024 32.32 Mn
Mar 31, 2024 32.32 Mn
Dec 31, 2023 -203.13 Mn
Dec 31, 2023 -203.13 Mn